Showing results (101-110 of 321) with videos related to

Sort By:
Pageof 33
Cancer Chemotherapy and Pharmacology|July 20, 2007
Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expressionAndrea Rocca, Giuseppe Viale, Richard D Gelber, et al.
Leukemia & Lymphoma|May 30, 2009
Early stage gastric diffuse large B-cell lymphomas: results of a randomized trial comparing chemotherapy alone versus chemotherapy + involved field radiotherapy. (IELSG 4). [corrected]Giovanni Martinelli, Federica Gigli, Liliana Calabrese, et al.
Cancer Treatment Reviews|November 27, 2018
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectivesFrancesca Corti, Federico Nichetti, Alessandra Raimondi, et al.
Hematological Oncology|February 10, 2026
Longitudinal Monitoring of Measurable Residual Disease in Chronic Lymphocytic Leukemia Patients Treated With Venetoclax: Results of a Prospective Multicenter Real-Life StudyLucia Farina, Alessandro Noto, Antonella Aiello, et al.
Cancer Research|November 5, 2011
The white adipose tissue used in lipotransfer procedures is a rich reservoir of CD34+ progenitors able to promote cancer progressionInes Martin-Padura, Giuliana Gregato, Paola Marighetti, et al.
Clinical Breast Cancer|December 19, 2012
Immunohistochemically defined subtypes and outcome of apocrine breast cancerSilvia Dellapasqua, Patrick Maisonneuve, Giuseppe Viale, et al.
Scientific Reports|October 7, 2015
Molecular investigation of coexistent chronic myeloid leukaemia and peripheral T-cell lymphoma - a case reportAlicja M Gruszka, Cristina Rabascio, Laura Cannella, et al.
Breast Cancer Research and Treatment|July 11, 2014
Prognostic relevance of peritumoral vascular invasion in immunohistochemically defined subtypes of node-positive breast cancerElisabetta Munzone, Vincenzo Bagnardi, Nicole Rotmensz, et al.
Clinical Lung Cancer|September 21, 2025
Refining High-Risk EGFR-Mutant Lung Cancer Patients: The Role of Adjusted Variant Allele Frequency in First-Line Osimertinib TherapyMarta Brambilla, Francesca Barbetta, Giuseppe Nardo, et al.
The Journal of Pathology|August 5, 2003
Immunoreactivity for cyclin D3 is frequently detectable in high-grade primary gastric lymphomas in the absence of the t(6;14)(p21.1;q32.3) chromosomal translocationGiancarlo Pruneri, Sonia Fabris, Roberta Fasani, et al.
Pageof 33